Improved antisaccade performance in schizophrenia with risperidone
- Department of Experimental Psychology, University of Sussex, Falmer, Brighton BN1 9QG, UK
- Correspondence to: Dr S B Hutton; samh{at}biols.susx.ac.uk
Atypical treatment improves cognitive function
Several recent studies have suggested that atypical antipsychotic medications such as risperidone can ameliorate certain cognitive deficits associated with schizophrenia.1 Such findings have important implications, as cognitive impairment is a significant predictor of both social and occupational functioning in schizophrenia. In this issue, Burke and Reveley (pp 449–454)2 show that patients treated with the atypical antipsychotic risperidone make fewer antisaccade errors than when they are treated …
